Form 4: CalciMedica Chief Business Officer Boosts Stake with Share Purchase

CalciMedica's Chief Business Officer, Director, and 10% Owner, Eric W. Roberts, acquired 1,500 shares of common stock, signaling increased insider confidence.

Summary

• Eric W. Roberts, who serves as Chief Business Officer, Director, and a 10% Owner of CalciMedica, Inc. (CALC), purchased shares of the company's common stock.
• The transaction occurred on July 22, 2025, involving the acquisition of 1,500 shares.
• The shares were purchased at a price of $3.775 per share.
• Following this transaction, Eric W. Roberts' total beneficial ownership in CalciMedica, Inc. stands at 1,013,910 shares.
• This total beneficial ownership includes 164,706 shares held directly and 849,204 shares held indirectly through various custodian accounts and investment vehicles (FMTC Custodian Roth IRA, Oppenheimer & Co Inc. Custodian Roth IRA, IRA Financial Trust Company, Valence Investments SPV IV, LLC, Valence Investments SPV V, LLC, and Valence Investments SPV VI, LLC).

Sentiment

Score: 8

Explanation: The purchase of shares by a high-ranking insider, who also holds significant ownership and board positions, is a strong positive signal, indicating deep conviction in the company's future performance.

Positives

• The purchase of shares by a high-ranking insider (Chief Business Officer, Director, and 10% Owner) indicates strong confidence in the company's current valuation and future prospects.
• Insider buying can often be interpreted as a positive signal by the market, suggesting that management believes the stock is undervalued or expects positive developments.

Related Party Transactions

• The reported transaction involves an insider (Eric W. Roberts) purchasing shares of the issuer, which is a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value and future growth, potentially increasing investor confidence.

Key Dates

Recommendation

The purchase of shares by a high-ranking insider, who is also a director and significant owner, signals strong confidence in CalciMedica's valuation and future performance, making it a favorable indicator for potential investors.

Keywords

CalciMedica, CALC, Insider Trading, Stock Purchase, Form 4, Eric W. Roberts, Chief Business Officer, Director, 10% Owner, Beneficial Ownership